Key result
Colchicine suppresses cholesterol crystal-induced endothelial pyroptosis and inflammation in vitro via AMPK/SIRT1 activation.
Why the study?
Cholesterol crystal-induced endothelial cell inflammation and pyroptosis contribute to atherosclerosis, but whether colchicine can alleviate this injury and its mechanisms remain unclear.
Does colchicine alleviate cholesterol crystal-induced endothelial cell pyroptosis in HUVECs?
Does colchicine alleviate cholesterol crystal-induced endothelial cell pyroptosis in HUVECs?
Colchicine alleviates cholesterol crystal-induced endothelial cell pyroptosis and oxidative stress by activating the AMPK/SIRT1 signaling pathway, providing a potential mechanism for its cardiovascular benefits.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for colchicine in endothelial protection; leaves open clinical translation pending in vivo and human studies.
Cholesterol crystal- (CC-) induced endothelial cell inflammation and pyroptosis play an important role in the development of cardiovascular diseases, especially in atherosclerosis (AS). Increasing evidence suggests that cholesterol crystals are known to be a pivotal pathological marker of atherosclerotic plaque vulnerability. As a classical nonspecific anti-inflammatory drug, colchicine has been widely used in the treatment of acute gout. However, whether colchicine could alleviate CC-induced endothelial cell injury and the related mechanisms remains to be addressed. In this study, the protective effect of colchicine on human umbilical vein endothelial cells (HUVECs) was confirmed. Our results revealed that after cotreatment with colchicine and cholesterol crystals in endothelial cells, the uptake of cholesterol crystals was significantly decreased, the cell viability was obviously increased, and the release of lactate dehydrogenase (LDH) and the number of pyroptotic cells decreased significantly; then, the expression of NLRP3 inflammasome-related proteins and various inflammatory factors was also visibly suppressed; moreover, as a potent activator of NLRP3 inflammasome, the intracellular ROS level was clearly reduced, while mitochondrial membrane potential improved significantly. In addition, the expression levels of AMP-dependent kinase (AMPK) pathway-related proteins as well as various antioxidant enzymes were elevated notably in varying degrees. However, the above effects of colchicine were completely offset by the treatment of siRNA targeting AMPKα and Sirtuin1 (SIRT1). Therefore, we conclude that colchicine plays a crucial role in alleviating the intracellular inflammatory response and NLRP3 inflammation activation, attenuating the levels of cellular oxidative stress and pyroptosis in endothelial cells via regulating AMPK/SIRT1 signaling, which may be a concrete mechanism for the secondary prevention of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2020) studied Cholesterol crystal-induced endothelial cell injury. Colchicine vs. Cholesterol crystals alone was evaluated on Cell viability, LDH release, pyroptosis, and expression of AMPK/SIRT1 pathway proteins. Colchicine alleviated cholesterol crystal-induced endothelial cell pyroptosis, oxidative stress, and inflammation in vitro by activating the AMPK/SIRT1 signaling pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: